Lymphoma types, prevalence, presentations, and treatment approaches vary significantly by age group. Key considerations span pediatric aggressive lymphomas, young adult cases, non-Hodgkin predominance in middle-age, advanced elderly cases, toxicity tolerances, and managing late effects.